Pharmaceutical News and Articles

Palvella Therapeutics Announces Positive Topline Results from Phase 3 SELVA Clinical Study of QTORIN™ 3.9% Rapamycin Anhydrous Gel in Microcystic Lymphatic Malformations

(Nasdaq PVLA) Palvella Therapeutics, Inc. (Palvella or the Company ), a clinical-stage biopharmaceutical company focused on developing and commercializing novel

Beren Therapeutics Announces FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann Pick Disease Type C

U.S. FDA Grants Full Approval to Pfizer’s Braftovi Combination Regimen in First-Line Metastatic Colorectal Cancer

Novo Nordisk Announces Significant Reduction in US List Price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines), Building on Continued Efforts to Expand Access

Plainsboro, NJ, US and Bagsv rd, Denmark, February 24, 2026 Today, Novo Nordisk announced that, effective January 1, 2027, the company will lower the list price

Zepbound (tirzepatide) Now Available in Multi-Dose KwikPen

FDA Grants Accelerated Approval to Loargys (pegzilarginase-nbln) for the treatment of Hyperargininemia in Patients with Arginase 1 Deficiency

Dry Powder Inhalers: A Double Win for COPD and Environment

TUESDAY, Feb. 24, 2026 Dry powder inhalers might provide a double benefit for people battling chronic obstructive pulmonary disease (COPD), a new study says. Th

Antibiotic-Resistant Bacteria Found in Many Pregnant Women, Newborns in the U.S.

A considerable proportion of pregnant women are colonized with enterobacterales with ampicillin (AmpR-E) and ceftriaxone resistance (CefR-E) in the United State

Dupixent (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)

Gap In Preventable Deaths Widening Between Those With, Without A College Degree

TUESDAY, Feb. 24, 2026 A gap in preventable deaths is growing between people with and without a college degree, a new study says. A steadily increasing number o